Transaction · 0001415889-25-005380

RA CAPITAL MANAGEMENT, L.P.

RA CAPITAL MANAGEMENT, L.P., DIR, reported a transaction classified as grant at Mineralys Therapeutics, Inc. involving 32900.000000 shares for an estimated $0.00. Reported holdings after the transaction were 32900.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code ADIR
MLYSMineralys Therapeutics, Inc.
Filing timeFeb 25
Trade dateFeb 13, 2025
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
…
Pre-filing
…
Returns since
…

MLYS price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
MLYS since 2025-02-25Filed 561 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
grant
Code A
Identifier
0001415889-25-005380
Stock Option (Right to Buy)
Transaction date
Feb 13, 2025
Filed Feb 25, 2025, 02:41 AM · 12d delay
Shares
32.9k sh
$0 per share
Estimated value
$0
Computed from shares × price
Holdings after
32.9k sh
Indirect · See Footnote

Filing warnings

Notes recorded with this filing
1 warning
delayed filingThe filing was reported 12 calendar days after the transaction date.

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Delayed Filing Derivative Transaction Large Holdings Increase
-22score
Filing-only score

-22

Compact filing score computed from stored Form 4 facts. Version v1.

Low filing signal

This filing has a meaningfully negative filing-only score. It is likely less useful as a positive insider-activity signal.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The stock option vests in 12 substantially equal monthly installments following the date of grant.

  2. F2

    RA Capital Management, L.P. (the "Adviser") is the investment manager for RA Capital Healthcare Fund, L.P. (the "Fund") and RA Capital Nexus III Fund, L.P. (the "Nexus Fund III"). The general partner…

  3. F3

    Derek DiRocco is a Partner of the Adviser who serves on the Issuer's board of directors. Under Dr. DiRocco's arrangement with the Adviser, Dr. DiRocco holds the option for the benefit of the Fund and…

Original filing · 0001415889-25-005380
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

MLYS